• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,315.04 0.00
( 0.00%)
Global Indices
Nasdaq
49,708.56 161.38
(0.33%)
Dow Jones
7,424.10 -5.40
(-0.07%)
Hang Seng
60,874.73 -534.56
(-0.87%)
Nikkei 225
10,297.25 101.88
(1.00%)
Forex
USD-INR
95.89 0.18
(0.19%)
EUR-INR
111.46 -0.47
(-0.42%)
GBP-INR
127.74 -1.27
(-0.99%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

ultratech cement ltd
Tatva Chintan Pharma Chem consolidated net profit rises 901.94% in the March 2026 quarter
May 18,2026
Net profit of Tatva Chintan Pharma Chem rose 901.94% to Rs 10.32 crore in the quarter ended March 2026 as against Rs 1.03 crore during the previous quarter ended March 2025. Sales rose 24.36% to Rs 134.14 crore in the quarter ended March 2026 as against Rs 107.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 636.43% to Rs 42.05 crore in the year ended March 2026 as against Rs 5.71 crore during the previous year ended March 2025. Sales rose 32.18% to Rs 505.86 crore in the year ended March 2026 as against Rs 382.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales134.14107.86 24 505.86382.71 32
OPM %20.978.30 -18.428.94 -
PBDT26.349.29 184 93.8635.24 166
PBT16.592.03 717 57.017.58 652
NP10.321.03 902 42.055.71 636